EGIS-7625 is a selective and competitive 5-HT2B receptor antagonist.

It is experimentally proven to be directly associated with smooth stomach muscle constriction of white rats in vivo, and variably effective in provoking a similar response in in vitro human stomach cells.

In high blood concentrations, it causes mild constriction of rabbit pulmonary arteries.

[1] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.